UK’s Milner Therapeutics Institute has launched the first functional genomics screening laboratory (FGSL) in collaboration with AstraZeneca, the University of Cambridge and the Medical Research Council. The lab, located in Cambridge, will offer arrayed CRISPR screening to explore the link between genes and diseases, and to identify potential targets for drug discovery across chronic conditions, such as cardiovascular and metabolic diseases. The first projects at the FGSL will study liver regeneration and inflammatory bowel disease.

ClickFix Captcha – A Creative Technique That Allow Attackers Deliver Malware and Ransomware on Windows
The ClickFix Captcha technique exploits user trust to distribute malware, including Quakbot. Users visiting malicious sites encounter a fake captcha directing them to perform actions